Literature DB >> 18226948

Evaluating daytime alertness in individuals with Restless Legs Syndrome (RLS) compared to sleep restricted controls.

Charlene Gamaldo1, Amy R Benbrook, Richard P Allen, Oluwamurewa Oguntimein, Christopher J Earley.   

Abstract

BACKGROUND AND
PURPOSE: Restless Legs Syndrome (RLS) is a common sensorimotor disorder often associated with significant chronic sleep loss. Previous studies looking at the effects of sleep loss on daytime function in RLS individuals, using subjective reporting techniques have yielded mixed results. In this study we used more objective measures of alertness and compared RLS subjects who are off treatments and chronically sleep restricted to chronic sleep-restricted controls. SUBJECTS AND METHODS: The final sample consisted of 20 RLS subjects (10 male and 10 female) and 13 sleep-restricted controls (seven male and six female). Thirteen controls underwent a 14-day chronic partial sleep-restriction protocol in order to closely match the degree of chronic sleep loss reportedly experienced by untreated RLS patients. On the final day of the protocol each subject performed a morning and evening Suggested Immobilization Test (SIT) which served as a modified Maintenance of Wakefulness Test (MWT). RLS and control groups were compared for differences in alertness as measured objectively by the sleep latency on the morning and evening SITs.
RESULTS: The RLS subjects had a longer sleep latency on the morning and evening SIT than controls (t=3.80, p=0.001, U=31.0, p<0.001, respectively). Even after controlling for the potential arousal impact associated with increased leg activity, RLS individuals still demonstrated a higher degree of objective alertness (p=0.023, p=0.006, Fisher's exact test).
CONCLUSIONS: RLS subjects, despite having, if anything, greater sleep loss, displayed greater sustained alertness than sleep-restricted controls. Thus, the heightened degree of alertness demonstrated by RLS patients may be in contrast to the perceived impairment in mood, vigor, and vigilance commonly reported in previous studies.

Entities:  

Mesh:

Year:  2008        PMID: 18226948      PMCID: PMC2650846          DOI: 10.1016/j.sleep.2007.11.024

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  18 in total

Review 1.  Restless legs syndrome: a review of clinical and pathophysiologic features.

Authors:  R P Allen; C J Earley
Journal:  J Clin Neurophysiol       Date:  2001-03       Impact factor: 2.177

2.  Restless legs syndrome prevalence and impact: REST general population study.

Authors:  Richard P Allen; Arthur S Walters; Jacques Montplaisir; Wayne Hening; Andrew Myers; Timothy J Bell; Luigi Ferini-Strambi
Journal:  Arch Intern Med       Date:  2005-06-13

3.  The range and nature of sleep dysfunction in untreated Parkinson's disease (PD). A comparative controlled clinical study using the Parkinson's disease sleep scale and selective polysomnography.

Authors:  V Dhawan; S Dhoat; A J Williams; A Dimarco; S Pal; A Forbes; A Tobías; P Martinez-Martin; K Ray Chaudhuri
Journal:  J Neurol Sci       Date:  2006-06-15       Impact factor: 3.181

4.  Insomnia screening in postacute traumatic brain injury: utility and validity of the Pittsburgh Sleep Quality Index.

Authors:  N L Fictenberg; S H Putnam; N R Mann; R D Zafonte; A E Millard
Journal:  Am J Phys Med Rehabil       Date:  2001-05       Impact factor: 2.159

5.  Restless legs syndrome: a clinical study of 55 patients.

Authors:  C L Bassetti; D Mauerhofer; M Gugger; J Mathis; C W Hess
Journal:  Eur Neurol       Date:  2001       Impact factor: 1.710

6.  Impact of sleep-related complaints on depressive symptoms in patients with restless legs syndrome.

Authors:  Magdolna Hornyak; Marta Kopasz; Mathias Berger; Dieter Riemann; Ulrich Voderholzer
Journal:  J Clin Psychiatry       Date:  2005-09       Impact factor: 4.384

Review 7.  Neurocognitive consequences of sleep deprivation.

Authors:  Jeffrey S Durmer; David F Dinges
Journal:  Semin Neurol       Date:  2005-03       Impact factor: 3.420

8.  Diagnosis and assessment of sleep and circadian rhythm disorders.

Authors:  Daniel J Buysse
Journal:  J Psychiatr Pract       Date:  2005-03       Impact factor: 1.325

9.  Maintenance of wakefulness test and multiple sleep latency test. Measurement of different abilities in patients with sleep disorders.

Authors:  R B Sangal; L Thomas; M M Mitler
Journal:  Chest       Date:  1992-04       Impact factor: 9.410

10.  The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research.

Authors:  D J Buysse; C F Reynolds; T H Monk; S R Berman; D J Kupfer
Journal:  Psychiatry Res       Date:  1989-05       Impact factor: 3.222

View more
  8 in total

1.  Presenting symptoms in pediatric restless legs syndrome patients.

Authors:  Al de Weerd; Irene Aricò; Rosalia Silvestri
Journal:  J Clin Sleep Med       Date:  2013-10-15       Impact factor: 4.062

2.  Restless legs syndrome, sleep, and quality of life among adolescents and young adults.

Authors:  Graciela E Silva; James L Goodwin; Kimberly D Vana; Monica M Vasquez; Peter G Wilcox; Stuart F Quan
Journal:  J Clin Sleep Med       Date:  2014-07-15       Impact factor: 4.062

Review 3.  Sleep-related movement disorders.

Authors:  Giovanni Merlino; Gian Luigi Gigli
Journal:  Neurol Sci       Date:  2011-12-28       Impact factor: 3.307

4.  Increased prevalence of restless legs syndrome in patients with acromegaly and effects on quality of life assessed by Acro-QoL.

Authors:  S Cannavò; R Condurso; M Ragonese; F Ferraù; A Alibrandi; I Aricò; G Romanello; S Squadrito; F Trimarchi; R Silvestri
Journal:  Pituitary       Date:  2011-12       Impact factor: 4.107

Review 5.  Brain-iron deficiency models of restless legs syndrome.

Authors:  Christopher J Earley; Byron C Jones; Sergi Ferré
Journal:  Exp Neurol       Date:  2022-06-30       Impact factor: 5.620

6.  Depressive disorders in restless legs syndrome: epidemiology, pathophysiology and management.

Authors:  Magdolna Hornyak
Journal:  CNS Drugs       Date:  2010-02       Impact factor: 5.749

7.  The prevalence of restless legs syndrome across the full spectrum of kidney disease.

Authors:  Jonathan Lee; David D M Nicholl; Sofia B Ahmed; Andrea H S Loewen; Brenda R Hemmelgarn; Jaime M Beecroft; Tanvir C Turin; Patrick J Hanly
Journal:  J Clin Sleep Med       Date:  2013-05-15       Impact factor: 4.062

Review 8.  New Insights into the Neurobiology of Restless Legs Syndrome.

Authors:  Sergi Ferré; Diego García-Borreguero; Richard P Allen; Christopher J Earley
Journal:  Neuroscientist       Date:  2018-07-26       Impact factor: 7.235

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.